Care Bare Rx vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Willow beats Care Bare Rx overall, scoring 8.2/10 vs 7.4/10. Care Bare Rx is more affordable at $199/mo vs $299/mo. Choose Care Bare Rx for users who prefer oral glp-1 pills and want a simple, no-appo. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Care Bare Rx and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Care Bare Rx

#31 of 48
7.4/10

Simple GLP-1 provider offering oral pill options with a streamlined no-appointment-needed process.

Visit Care Bare Rx
Higher Rated

Willow

#8 of 48
8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow
FeatureCare Bare RxWillow
Our Score7.4/108.2/10
Starting Price$199/mo$299/mo
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForUsers who prefer oral GLP-1 pills and want a simple, no-appointment processUsers who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking#31#8

Pros & Cons Compared

Care Bare Rx

Pros

  • +Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate — flexibility to switch formats
  • +Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
  • +Same price at every dose with no hidden fees — simple, transparent billing
  • +Free shipping included on all orders

Cons

  • No publicly available company information — founding date, headquarters, and pharmacy partners are undisclosed
  • Very limited independent reviews — difficult to verify patient satisfaction or reliability
  • No insurance acceptance — cash-pay only with no HSA/FSA eligibility disclosed

Willow

Pros

  • +Includes monthly provider check-ins and dose adjustments at no extra cost
  • +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
  • +$299/mo all-in for compounded semaglutide with monthly provider support
  • +90%+ patient retention rate after 3 months per their published outcomes data

Cons

  • Compounded-only — no brand-name Wegovy or Zepbound through the platform
  • Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
  • Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
  • Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Care Bare Rx with a score of 8.2/10 vs 7.4/10. If budget is your priority, Care Bare Rx starts at $199/mo compared to Willow's $299/mo. Care Bare Rx offers both brand-name and compounded medications, giving you more flexibility. Choose Care Bare Rx if you want: users who prefer oral glp-1 pills and want a simple, no-appointment process. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Care Bare Rx nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Care Bare Rx

Starting at $199/mo

Visit Care Bare Rx

Try Willow

Starting at $299/mo

Visit Willow

Related comparisons

Other matchups readers comparing Care Bare Rx or Willow tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.